Used in research and development for studying lymphangiogenesis and tumor metastasis due to its specific binding to VEGF-C. It serves as a critical tool in blocking VEGF-C interaction with its receptor VEGFR-3, thereby inhibiting lymphatic vessel formation in preclinical models. Commonly applied in cancer biology to assess the role of VEGF-C signaling in tumor progression and spread. Also utilized as a reference reagent in antibody validation and assay development for therapeutic targeting of the VEGF-C/VEGFR-3 pathway.